SRGA - Surgalign revenue of $20.62M misses by $0.51M reconfirms full-year revenue
- Surgalign press release ( NASDAQ: SRGA ): Q2 GAAP EPS of -$0.86 beats by $1.54 .
- Revenue of $20.62M (-17.0% Y/Y) misses by $0.51M .
- Shares -2.5% .
- Fiscal 2022 Business Outlook
- The Company has reconfirmed its full year revenue outlook to be in the range of $86 to $90 million. ($86.53M consensus)
For further details see:
Surgalign revenue of $20.62M misses by $0.51M, reconfirms full-year revenue